Keyphrases
Active Role
11%
Advanced Lung Adenocarcinoma
11%
Anoikis Resistance
11%
Breast Cancer Patients
11%
Cancer Aggressiveness
100%
Cancer Cell Migration
11%
Cancer Cell Stemness
11%
Cancer Invasion
11%
Cancer Therapy
11%
Cancer-associated Fibroblasts
11%
Carcinoma Cells
11%
Cell Components
11%
Cell Sphere
11%
Cell Surface Receptor
22%
Chemoresistance
11%
Chondroitin Sulfate Proteoglycans
11%
Claudin-1
33%
Cluster of Differentiation 44 (CD44)
100%
Combined Therapy
11%
Epithelial-mesenchymal Transition
11%
Function Approach
11%
Gain-of-function
11%
Liver
11%
Loss Function
11%
Lung
11%
Lung Cancer Cells
11%
Malignant Phenotype
11%
Nanog
11%
Non-small Cell Lung Cancer (NSCLC)
100%
Non-small Cell Lung Cancer Cells
22%
Poor Prognosis
11%
Serglycin
100%
Sphere Formation
11%
Stromal Cells
11%
Stromal Component
11%
Tumor Cell Microenvironment
11%
Tumor Cells
33%
Tumor Growth
11%
Tumor Microenvironment
100%
Tumor Progression
11%
Type I Cells
11%
Vimentin Expression
11%
Immunology and Microbiology
Anoikis
14%
Cancer Associated Fibroblast
14%
Cancer Cell
42%
CD44
100%
Cell Invasion
14%
Cell Migration
14%
Cell Surface
14%
Chondroitin Sulfate Proteoglycan
14%
Claudin
42%
Drug Resistance
14%
Epithelial Mesenchymal Transition
14%
Tumor Cell
57%
Biochemistry, Genetics and Molecular Biology
Anoikis
11%
Cancer Cell
33%
CD44
100%
Cell Invasion
11%
Cell Migration
11%
Cell Surface Receptor
11%
Chondroitin Sulfate Proteoglycan
11%
Claudin
33%
Drug Resistance
11%
Fibroblast
11%
Mesenchymal-Epithelial Transition
11%
Nanog
11%
Stromal Cell
11%
Tumor Progression
22%
Vimentin
11%